Liberty Mutual Group Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Liberty Mutual Group Asset Management's BMY Position: Q4 2018 in Review
Liberty Mutual Group Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 65,336 shares — an estimated $4.06M sold.
Liberty Mutual Group Asset Management first reported a position in BMY in Q2 2013 and held it in 22 quarters. The position peaked at $8.62M in Q2 2016. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.
- Liberty Mutual Group Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
- Liberty Mutual Group Asset Management sold 65,336 Bristol-Myers Squibb shares in Q4 2018, an estimated $4.06M.
- Liberty Mutual Group Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 22 quarters.
- Liberty Mutual Group Asset Management's Bristol-Myers Squibb position peaked at $8.62M in Q2 2016.
- 1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.
Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.